Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Yo-yo” dieting -- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among p ...

Both high-protein and low-carb diets are effective for weight loss. Consuming more protein may be the most important factor ...

If you're trying to lose weight, there are a few things you can do that will help target specific areas of your body - and it ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Hitting a weight loss plateau can feel like running into a brick wall on a road you’ve been traveling so diligently. You’ve ...

Ketia Osibogun's 136 lbs transformation is a reminder that anyone can lose weight if they are meticulous. Read about the tips ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...